666 related articles for article (PubMed ID: 25096824)
1. Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines.
Weng J; Wang C; Wang Y; Tang H; Liang J; Liu X; Huang H; Hou J
Oral Oncol; 2014 Oct; 50(10):983-90. PubMed ID: 25096824
[TBL] [Abstract][Full Text] [Related]
2. Decrease of autophagy activity promotes malignant progression of tongue squamous cell carcinoma.
Wang Y; Wang C; Tang H; Wang M; Weng J; Liu X; Zhang R; Huang H; Hou J
J Oral Pathol Med; 2013 Aug; 42(7):557-64. PubMed ID: 23464740
[TBL] [Abstract][Full Text] [Related]
3. Silencing RhoA inhibits migration and invasion through Wnt/β-catenin pathway and growth through cell cycle regulation in human tongue cancer.
Yan G; Zou R; Chen Z; Fan B; Wang Z; Wang Y; Yin X; Zhang D; Tong L; Yang F; Jiang W; Fu W; Zheng J; Bergo MO; Dalin M; Zheng J; Chen S; Zhou J
Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):682-90. PubMed ID: 25001480
[TBL] [Abstract][Full Text] [Related]
4. [Effect of autophagy gene Beclin 1 on the growth of cervical cancer HeLa cells in vitro and vivo].
Wang ZH; Li L; Peng ZL; Duan ZL
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):804-9. PubMed ID: 22335943
[TBL] [Abstract][Full Text] [Related]
5. Obovatol inhibits the growth and aggressiveness of tongue squamous cell carcinoma through regulation of the EGF‑mediated JAK‑STAT signaling pathway.
Duan M; Du X; Ren G; Zhang Y; Zheng Y; Sun S; Zhang J
Mol Med Rep; 2018 Aug; 18(2):1651-1659. PubMed ID: 29845251
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts confer cisplatin resistance of tongue cancer via autophagy activation.
Liao JK; Zhou B; Zhuang XM; Zhuang PL; Zhang DM; Chen WL
Biomed Pharmacother; 2018 Jan; 97():1341-1348. PubMed ID: 29156523
[TBL] [Abstract][Full Text] [Related]
7. The downregulation of ANGPTL4 inhibits the migration and proliferation of tongue squamous cell carcinoma.
Huang Z; Xie J; Lin S; Li S; Huang Z; Wang Y; Ye J
Arch Oral Biol; 2016 Nov; 71():144-149. PubMed ID: 27505034
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of Beclin‑1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma.
Hu Z; Zhong Z; Huang S; Wen H; Chen X; Chu H; Li Q; Sun C
Mol Med Rep; 2016 Aug; 14(2):1567-73. PubMed ID: 27356955
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
10. High expression of TMEM40 contributes to progressive features of tongue squamous cell carcinoma.
Zhang Q; Huang D; Zhang Z; Feng Y; Fu M; Wei M; Zhou J; Huang Y; Liu S; Shi R
Oncol Rep; 2019 Jan; 41(1):154-164. PubMed ID: 30320346
[TBL] [Abstract][Full Text] [Related]
11. Beclin1 overexpression inhibitis proliferation, invasion and migration of CaSki cervical cancer cells.
Sun Y; Liu JH; Sui YX; Jin L; Yang Y; Lin SM; Shi H
Asian Pac J Cancer Prev; 2011; 12(5):1269-73. PubMed ID: 21875280
[TBL] [Abstract][Full Text] [Related]
12. HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma.
Zhang H; Tang Z; Deng C; He Y; Wu F; Liu O; Hu C
Oral Dis; 2017 Mar; 23(2):255-264. PubMed ID: 27809392
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
14. miR-29b suppresses proliferation, migration, and invasion of tongue squamous cell carcinoma through PTEN-AKT signaling pathway by targeting Sp1.
Jia LF; Huang YP; Zheng YF; Lyu MY; Wei SB; Meng Z; Gan YH
Oral Oncol; 2014 Nov; 50(11):1062-71. PubMed ID: 25127200
[TBL] [Abstract][Full Text] [Related]
15. Suppression of tongue squamous cell carcinoma growth by inhibition of Jagged1 in vitro and in vivo.
Zhang TH; Liu HC; Liang YJ; Liang LZ; Zheng GS; Huang HZ; Wu JN; Liao GQ
J Oral Pathol Med; 2013 Apr; 42(4):322-31. PubMed ID: 23157415
[TBL] [Abstract][Full Text] [Related]
16. Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway.
Chen W; Wu K; Zhang H; Fu X; Yao F; Yang A
Eur J Pharmacol; 2018 Nov; 839():33-39. PubMed ID: 30244004
[TBL] [Abstract][Full Text] [Related]
17. FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT).
Jiao J; Zhao X; Liang Y; Tang D; Pan C
Biochem Biophys Res Commun; 2015 Oct; 466(3):327-32. PubMed ID: 26362179
[TBL] [Abstract][Full Text] [Related]
18. High expression of Notch2 drives tongue squamous cell carcinoma carcinogenesis.
Gan RH; Lin LS; Zheng DP; Zhao Y; Ding LC; Zheng DL; Lu YG
Exp Cell Res; 2021 Feb; 399(1):112452. PubMed ID: 33382997
[TBL] [Abstract][Full Text] [Related]
19. [hsa_circ_0000231 affects the progression of tongue squamous cell carcinoma by activating Wnt/β-catenin signaling pathway].
Chen QW; Wang DQ; Ding BX; Tang MM; Li XG; Zhou JY; Xu K; Fang ZR; Han L; Wu H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Oct; 57(10):1230-1239. PubMed ID: 36319130
[No Abstract] [Full Text] [Related]
20. miR-34a inhibits migration and invasion of tongue squamous cell carcinoma via targeting MMP9 and MMP14.
Jia LF; Wei SB; Mitchelson K; Gao Y; Zheng YF; Meng Z; Gan YH; Yu GY
PLoS One; 2014; 9(9):e108435. PubMed ID: 25268950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
